Management of Helicobacter pylori-related diseases / / Akiko Shiotani, David Y. Graham
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Autore: |
Shiotani Akiko
|
| Titolo: |
Management of Helicobacter pylori-related diseases / / Akiko Shiotani, David Y. Graham
|
| Pubblicazione: | Philadelphia, Pennsylvania : , : Elsevier, , 2015 |
| ©2015 | |
| Descrizione fisica: | 1 online resource (246 p.) |
| Disciplina: | 579.34 |
| Soggetto topico: | Helicobacter pylori |
| Persona (resp. second.): | GrahamDavid Y. |
| Note generali: | "Clinics Review Articles." |
| Nota di bibliografia: | Includes bibliographical references at the end of each chapters and index. |
| Nota di contenuto: | Cover image; Title page; Table of Contents; Copyright Page; Contributors; Consulting Editor; Editors; Authors; Forthcoming Issues; Forthcoming Issues; Recent Issues; Foreword: Helicobacter pylori; Preface: Helicobacter pylori: New Thoughts and Practices; Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era; Key points; Introduction; Invasive tests; Serology; Summary: diagnosis of Helicobacter pylori infection in the proton pump inhibitors era; Practical Aspects in Choosing a Helicobacter pylori Therapy; Key points; Introduction; Choice of therapy; First-line regimens |
| Rescue therapyProbiotics; Summary; How to Effectively Use Bismuth Quadruple Therapy; Key points; Background; Bismuth in the era of new concepts regarding pathogenesis and treatment of peptic ulcer; Bismuth quadruple therapy for H pylori eradication; The effect of metronidazole resistance as examined by meta-analysis; Calculation of the effectiveness of bismuth quadruple therapy; Adherence (compliance) with bismuth quadruple therapy; How to make bismuth quadruple therapy more acceptable; Doxycycline | |
| Examination of outcome in regions where bismuth quadruple therapy frequently fails (eg, Turkey and Iran)Bismuth, tetracycline, amoxicillin, proton pump inhibitors quadruple therapy; Bismuth sequential therapies; Information needed to obtain generalizable results; Issues ripe for systematic study; Proton pump inhibitors dosage; Efficient study design; Recommendations; Is There a Role for Probiotics in Helicobacter pylori Therapy?; Key points; What probiotics are; Probiotics; Probiotics as adjuvant therapy for Helicobacter pylori eradication; Probiotics as cure for Helicobacter pylori infection | |
| SummaryMolecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance; Key points; Molecular determination of Helicobacter pylori resistance to macrolides; Molecular determination of Helicobacter pylori resistance to fluoroquinolones; Molecular determination of Helicobacter pylori resistance to tetracycline; Molecular determination of Helicobacter pylori resistance to other antibiotics; When Is Endoscopic Follow-up Appropriate After Helicobacter pylori Eradication Therapy?; Key points; Introduction; Helicobacter pylori eradication; Uninvestigated and nonulcer dyspepsia | |
| Peptic ulcerPremalignant gastric lesions and early gastric cancer; Hereditary risk for gastric cancer; Mucosa-associated lymphoid tissue lymphoma; Summary; Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication; Key points; Introduction; Helicobacter pylori infection is the most important determinant of gastric cancer risk; Gastric cancer risk: epidemiologic trends; Gastric cancer risk: the assessment; Gastric cancer risk in eradicated patients; Summary; Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer; Key points; Introduction | |
| Classifications and characterizations of gastric cancer | |
| Titolo autorizzato: | Management of Helicobacter pylori-related diseases |
| ISBN: | 0-323-39566-X |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910137117303321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |
Serie:
Gastroenterology clinics of North America ; ; Volume 44, Number 3.